China SXT Pharmaceuticals (SXTC) Non-Current Assets (2018 - 2026)

China SXT Pharmaceuticals has reported Non-Current Assets for 9 years, with the latest figure at $244852.0 in Q1 2026.

• On a quarterly basis, Non-Current Assets fell 33.29% year-over-year to $244852.0 in Q1 2026; TTM through Mar 2026 was $244852.0, a 33.29% decrease from a year earlier, with the FY2026 full-year figure at $244852.0, down 33.29% from the prior year.
• Non-Current Assets was $244852.0 for Q1 2026 at China SXT Pharmaceuticals, down from $310889.0 in the prior quarter.
• The five-year high for Non-Current Assets was $11.1 million in Q1 2022, with the low at $244852.0 in Q1 2026.
• Average Non-Current Assets over 5 years is $5.7 million, with a median of $8.9 million recorded in 2024.
• The sharpest annual moves came in 2024 and 2025: Non-Current Assets soared 724.5% in 2024, then tumbled 96.55% in 2025.
• Over 5 years, Non-Current Assets stood at $9.8 million in 2022, then sank by 88.87% to $1.1 million in 2023, then jumped by 724.5% to $9.0 million in 2024, then sank by 96.55% to $310889.0 in 2025, then dropped by 21.24% to $244852.0 in 2026.
• The last three Non-Current Assets figures came in at $244852.0 (Q1 2026), $310889.0 (Q3 2025), and $367017.0 (Q1 2025), per Business Quant data.